Stennicke, Henning R <br/><br/>
A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.  [electronic resource] 

 -  Blood  Mar 2013 
 - 2108-16 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2012-01-407494  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CHO Cells<br/>Cells, Cultured<br/>Cricetinae<br/>Cricetulus<br/>Disease Models, Animal<br/>Factor VIII--administration & dosage<br/>Female<br/>Glycosylation<br/>Hemophilia A--drug therapy<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Models, Biological<br/>Polyethylene Glycols--administration & dosage<br/>Rabbits<br/>Rats<br/>Rats, Sprague-Dawley<br/>Time Factors<br/>Treatment Outcome